With an infinite mindset and holistic understanding of chronic eye diseases, we are dedicated to developing and commercializing less invasive technologies. We focus on targeting the underlying diseases and empowering eyecare providers to intervene earlier in disease progression.
OMNI® enables comprehensive glaucoma procedures that target three areas of resistance: Trabecular meshwork, Schlemm’s canal, and the collector channels.
Experience the Ergo-Series of the OMNI® Surgical System
The cannula tip has a new profile that enables gentle and precise access to Schlemm’s canal while continuing to enable full 360-degree catheterization associated with the OMNI procedure.
Enhancements enable surgeons to more easily rotate and position the cannula tip within Schlemm’s canal with precise finger rotations versus wrist adjustments.
The handle’s viscoelastic Luer connector is removable and detaches when the viscoelastic cartridge is removed, resulting in more clearance with the surgical microscope.
The OMNI® Surgical System is indicated for the catheterization and transluminal viscodilation of Schlemm’s canal and the cutting of trabecular meshwork to reduce intraocular pressure in adult patients with open-angle glaucoma.
There are risks with any glaucoma surgery procedure. In a clinical study of the OMNI Surgical System, the most common (>5%) post-operative adverse events reported were posterior capsule opacity (15%), mild anterior chamber inflammation (11%), cystoid macular edema (5%), corneal edema (5%) and IOP increase >10mmHg above baseline >30 days post-operative (5%). Please talk to your doctor for complete risk information, and to discuss whether treatment with the OMNI Surgical System is right for you.
The SION® Surgical Instrument is a sterile, single use, manually operated device used in ophthalmic surgical procedures to excise trabecular meshwork.
Do not use the SION if there is inadequate corneal clarity, or poor visualization of angle structures or in any situations where the anterior chamber angle has been damaged (i.e., from trauma or surgery) or it may not be possible to pass the device through Schlemm’s canal.
SION is contraindicated in patients: with angle recession, neovascular glaucoma, chronic angle closure, narrow angle glaucoma, narrow inlets with plateau iris, peripheral anterior synechiae, traumatic, malignant, or uveitic glaucoma; it is also contraindicated in patients who have had previous argon laser trabeculoplasty, ab interno devices implanted in or through Schlemm’s Canal, or prior incisional glaucoma surgery including trabeculotomy, goniotomy.
Always maintain direct microscopic and gonioscopic visualization of the instrument tip during the procedure to avoid inadvertently damaging intraocular structures. Avoid touching the SION® tip to any surfaces as this may damage it. Do not use the SION® tip to create a corneal incision.
Adverse events that may be reasonably associated with the use of the instrument include but are not limited to the following: anterior chamber shallowing, prolonged, or persistent intraocular inflammation, aqueous misdirection, choroidal effusion, suprachoroidal hemorrhage, Descemet’s membrane tear or detachment, corneal decompensation, corneal injury, corneal edema or opacification, intracorneal hematoma, cyclodialysis cleft, damage to posterior wall of Schlemm’s canal, hyphema, hypopyon, hypotony, hypotonic maculopathy, IOL dislocation, iris injury, tear, or iridodialysis, loss of vitreous, perforation of sclera, posterior capsular bag rupture, posterior capsule opacification, proliferative vitreoretinopathy, pupillary block, pupillary membrane formation, retinal detachment, retinal dialysis, retinal tears, vitreous hemorrhage, elevated IOP requiring treatment and endophthalmitis.
The TearCare® System is intended for the application of localized heat therapy in adult patients with evaporative dry eye disease due to meibomian gland dysfunction (MGD), when used in conjunction with manual expression of the meibomian glands.
The TearCare® System is contraindicated for patients with:
Potential adverse events may include but are not limited to:
